The Mystery of Mutated Blood

Chapter 10 Military corporations

***

The Araсura Corporation closely followed the events surrounding the Navadsaki Corporation and the leak of information. They learned that Navadsaki was receiving significant criticism for unethical practices and were looking for ways to distance themselves from such negative coverage. Aracura executives saw this as an opportunity to take advantage of the situation and gain a competitive advantage in the market.

One of the best scientists, Dr. Kaito, worked on a revolutionary vaccine called "FSR-305". This vaccine was designed to protect against all known diseases and poisons, making it a highly sought after commodity. Arakura's leaders knew that if they could take advantage of the public's growing distrust of Navadsaki and present themselves as a more ethical and trustworthy corporation, they could capture the market for this revolutionary vaccine.

They immediately began developing a marketing campaign to demonstrate the vaccine's effectiveness and safety. They contacted trusted publications and news agencies to promote their product and hired a team of public relations experts to help craft their message. They knew that the key to success was to get the public to believe in their product and trust their corporation.

Meanwhile, Mirandel and Celias corporations were also closely monitoring the situation. They understood that the fall of Navadsaki could mean a potential loss of profits for their own companies, and they were determined not to allow them to suffer the same fate. They too have started developing marketing strategies and approaching reliable sources to promote their products and services.

As public backlash against Navadsaki intensified, Arakura's campaign gained momentum. The media began reporting on the success of the vaccine, and people began lining up to get the vaccine. Other corporations quickly followed suit, and soon vaccines and other medical procedures were touted as safe, ethical, and effective.

Despite Navadsaki's efforts to contain the damage, public outrage continued to grow. Corporate profits began to decline as more people turned to competitors for health care. Other corporations took this as a warning and redoubled their efforts to distance themselves from Navadsaki's practices.

The board of directors of the Aracura Corporation held an emergency meeting to discuss the recent leak of information about the Navadsaki Corporation. As they sat at the table, the CEO, Mr. Takahashi, spoke.

"I think it's clear that we have a huge opportunity," he said. "We have what Navadsaki does not have - a vaccine that can cure any disease or poison. We must use this to our advantage."

The other council members nodded in agreement. One of them, Ms. Sato, stepped forward. "But we have to be careful," she said. "If we don't, we could end up in the same position as Navadsaki."

"What are you offering?" Mr. Takahashi asked.

"We need to be transparent," Ms. Sato responded. "We need to make sure the public knows what we're doing and that we're not hiding anything. We need to show them that we're using our technology for good."

The board members discussed the idea for several minutes, and eventually everyone agreed. They decided to hold a press conference to announce their vaccine and explain how it could benefit humanity. They also decided to donate a portion of their profits to charity to further demonstrate their commitment to good causes.

As they continued their discussion, the board of directors received a call from Mirandel Corporation, another major player in the biotech industry. The CEO of Mirandel, Mr. Hernandez, was on the line.

"Have you seen the news about Navadsaki?" - he asked.

"Yes, that's true," Mr. Takahashi replied. "We are currently discussing how we can use this to our advantage."